|
Mr. Todd Patrick joined ID Biomedical in 1994 as the President of its then newly created vaccine subsidiary, ID Vaccine. At that time, the parent company, ID Biomedical, was spending almost all of its resources on diagnostic product development and had a market capitalization of approximately $50 million. In 1999, Mr. Patrick was appointed President and Chief Operating Officer of ID Biomedical and with Dr. Holler, was charged with building the company’s capabilities in vaccine development. Prior to joining ID Biomedical, Mr. Patrick was employed by the University of California, Los Angeles (UCLA) as the Director of the Office of Intellectual Property Administration, where he was responsible for the patenting and licensing of intellectual property arising out of UCLA. | 